Editorial: Combating Diabetes and Diabetic Kidney Disease

Swayam Prakash Srivastava; Keizo Kanasaki; Julie E Goodwin

doi:10.3389/fphar.2021.716029

Editorial: Combating Diabetes and Diabetic Kidney Disease

Front Pharmacol. 2021 Jul 8:12:716029. doi: 10.3389/fphar.2021.716029. eCollection 2021.

Authors

Swayam Prakash Srivastava^{1

2}, Keizo Kanasaki³, Julie E Goodwin^{1

2}

Affiliations

¹ Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States.
² Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, United States.
³ Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.

No abstract available

Keywords: DPP-4 inhibitors; EndMT; SGLT-2 inhibitors; diabetes; diabetic kidney disease; long noncoding RNAs; microRNAs; mineralocorticoid receptor antagonism.

Publication types

Editorial